| Mays Cancer Center conducts clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma |
|
|
|
|
| |
|
| |
The latest breast cancer news from News Medical |
|
|
|
|  | | | | |  Scientists to discuss the latest cancer therapies, advances in PSMA PET scans and many more at ASCO Physicians and scientists from the UCLA Jonsson Comprehensive Cancer Center will discuss the latest research and clinical trial results on combination therapies for breast cancer, a potential new treatment for patients with recurrent glioma, and advances in PSMA PET guided radiotherapy for patients with prostate cancer, among other topics, at the American Society of Clinical Oncology's annual meeting. | |  | | | | |  Addressing sexual health issues of breast cancer patients on endocrine therapy Breast cancer treatments that can save a woman's life can seriously harm her sexual health, says Dr. Kristin E. Rojas, a breast cancer surgeon at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. | | | | | | |  Screening delays during the COVID-19 pandemic likely to increase cancer cases Delays in cancer screening during the COVID-19 pandemic will likely cause a significant increase in cancer cases that could have been caught earlier with screening, and may now be diagnosed at later stages, placing an increased burden on an already strained healthcare system, according to a new research article published in the Journal of the American College of Surgeons. | |
|
|
|  | | |  This article talks about a prospective cohort study that indicated HRD testing could accurately predict the sensitivity of platinum-based chemotherapy for ovarian cancer patients. | | | | |  Several phase 3 studies conducted by researchers from Dana-Farber Cancer Institute show promising results for patients with rectal, brain, and kidney cancers. The results of these studies, along with dozens of others led by Dana-Farber researchers, will be presented at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. | | | | |  Women with obesity when they are diagnosed with early breast cancer have a higher risk of recurrence or a second cancer compared to women whose weight is in the normal range and it can be hard to lose weight after being diagnosed with breast cancer. | | | | |  Researchers at Baylor College of Medicine have discovered a crucial regulator of the anti-cancer immune response that could change the game in the fight against cancer. | | | | |  A new research paper was published in Oncotarget's Volume 14 on May 19, 2023, entitled, "G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis." | | | | |  CAR-T therapy is now seeing expansion for use in cancer treatment. Sino Biological produces a large range of promising target antigens for use in the cell therapy of solid tumors. | |
|
|
|
|
|
|
|
